Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00484_DB01168_nanopub.RAK-7W81iqPp_MKxOxYaJVYcujyx303Cip5DEvO4a7Mm4#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00484_DB01168 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00484_DB01168 label "DDI between Brimonidine and Procarbazine - MAO Inhibitors like procarbazine may enhance the hypertensive effect of Alpha2-Agonists (Ophthalmic). The concomitant use of monoamine oxidase inhibitors and ophthalmic alpha2 agonists is contraindicated. [drugbank_resource:DB00484_DB01168]" assertion.
- drugbank_resource:DB00484_DB01168 identifier "drugbank_resource:DB00484_DB01168" assertion.
- drugbank_resource:DB00484_DB01168 title "DDI between Brimonidine and Procarbazine - MAO Inhibitors like procarbazine may enhance the hypertensive effect of Alpha2-Agonists (Ophthalmic). The concomitant use of monoamine oxidase inhibitors and ophthalmic alpha2 agonists is contraindicated." assertion.
- drugbank:DB00484 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00484_DB01168 assertion.
- drugbank:DB01168 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00484_DB01168 assertion.